November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
November 2, 2024 Tech Titans’ Mixed Results Stall Wall Street Bull Run
October 28, 2024 Recent Oil Slides In Global Markets, Japan In Flux
Tesla’s Valuation: Unsupported By Fundamentals Or Future Growth
Tesla Stock Doesn’t Deserve This Rally
Nvidia: Q3 Earnings Could Ignite $200 Rally
Tesla: When Fundamentals Don’t Matter (Rating Downgrade)
Amazon Q3: Stop Buying The Stock For Now Because It’s Overvalued
October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Arbutus Biopharma (ABUS) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: November 14, 2024 (08:54)
Sector: HealthcareThe share price of Arbutus Biopharma Corp. (ABUS) now
Are you interested in Arbutus Biopharma Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arbutus Biopharma stock price in 2024, 2025, 2026. How much will one Arbutus Biopharma share be worth in 2024 - 2026?
When should I take profit in Arbutus Biopharma stock? When should I record a loss on Arbutus Biopharma stock? What are analysts' forecasts for Arbutus Biopharma stock? What is the future of Arbutus Biopharma stock? We forecast Arbutus Biopharma stock performance using neural networks based on historical data on Arbutus Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Arbutus Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Arbutus Biopharma shares. This happens once a day.
Historical and forecast chart of Arbutus Biopharma stock
The chart below shows the historical price of Arbutus Biopharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Arbutus Biopharma stock price can be found in the table below.
Long-term forecasts by years.
Arbutus Biopharma Corporation, a biopharmaceutical company, is engaged in the discovery, development and commercialization of a drug for patients with chronic hepatitis B virus (HBV) infection in the United States. Its HBV product portfolio consists of AB-836, a capsid inhibitor that can inhibit HBV replication by preventing the assembly of functional viral capsids; and AB-423, which is undergoing preclinical studies. The company is also developing RNAi preparations that use the RNA interference pathway, which allows a new approach to the treatment of diseases.
Arbutus Biopharma daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Nov 16 | 3.66 | 3.59 | 3.74 | 4.41 |
Nov 17 | 3.63 | 3.58 | 3.70 | 3.49 |
Nov 18 | 3.67 | 3.62 | 3.75 | 3.80 |
Nov 19 | 3.69 | 3.63 | 3.78 | 4.06 |
Nov 20 | 3.77 | 3.71 | 3.84 | 3.42 |
Nov 21 | 3.75 | 3.70 | 3.78 | 2.16 |
Nov 22 | 3.75 | 3.73 | 3.83 | 2.72 |
Nov 23 | 3.75 | 3.72 | 3.79 | 1.90 |
Nov 24 | 3.71 | 3.63 | 3.75 | 3.19 |
Nov 25 | 3.74 | 3.71 | 3.80 | 2.26 |
Nov 26 | 3.75 | 3.68 | 3.83 | 3.87 |
Nov 27 | 3.80 | 3.77 | 3.87 | 2.75 |
Nov 28 | 3.83 | 3.76 | 3.86 | 2.66 |
Nov 29 | 3.83 | 3.76 | 3.87 | 3.03 |
Nov 30 | 3.85 | 3.79 | 3.89 | 2.65 |
Dec 01 | 3.96 | 3.87 | 4.05 | 4.54 |
Dec 02 | 4.03 | 3.97 | 4.12 | 3.87 |
Dec 03 | 4.11 | 4.03 | 4.15 | 3.15 |
Dec 04 | 4.12 | 4.06 | 4.19 | 3.17 |
Dec 05 | 4.14 | 4.04 | 4.18 | 3.47 |
Dec 06 | 4.14 | 4.11 | 4.20 | 2.36 |
Dec 07 | 4.14 | 4.04 | 4.17 | 3.29 |
Dec 08 | 4.20 | 4.14 | 4.24 | 2.47 |
Dec 09 | 4.33 | 4.24 | 4.37 | 3.12 |
Dec 10 | 4.41 | 4.35 | 4.47 | 2.89 |
Dec 11 | 4.41 | 4.34 | 4.50 | 3.63 |
Dec 12 | 4.39 | 4.34 | 4.48 | 3.22 |
Dec 13 | 4.28 | 4.23 | 4.37 | 3.25 |
Dec 14 | 4.31 | 4.24 | 4.36 | 2.71 |
Dec 15 | 4.37 | 4.28 | 4.45 | 3.83 |
Arbutus Biopharma Daily Price Targets
Arbutus Biopharma Stock Forecast 11-16-2024.
Forecast target price for 11-16-2024: $3.66.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 4.222%.
Pessimistic target level: 3.59
Optimistic target level: 3.74
Arbutus Biopharma Stock Forecast 11-17-2024.
Forecast target price for 11-17-2024: $3.63.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.376%.
Pessimistic target level: 3.58
Optimistic target level: 3.70
Arbutus Biopharma Stock Forecast 11-18-2024.
Forecast target price for 11-18-2024: $3.67.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.665%.
Pessimistic target level: 3.62
Optimistic target level: 3.75
Arbutus Biopharma Stock Forecast 11-19-2024.
Forecast target price for 11-19-2024: $3.69.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.901%.
Pessimistic target level: 3.63
Optimistic target level: 3.78
Arbutus Biopharma Stock Forecast 11-20-2024.
Forecast target price for 11-20-2024: $3.77.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.303%.
Pessimistic target level: 3.71
Optimistic target level: 3.84
Arbutus Biopharma Stock Forecast 11-21-2024.
Forecast target price for 11-21-2024: $3.75.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 2.115%.
Pessimistic target level: 3.70
Optimistic target level: 3.78
ABUS (ABUS) Monthly Stock Prediction for 2024
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Dec. | 3.66 | 3.39 | 3.80 | 10.81 |
Arbutus Biopharma forecast for this year
Arbutus Biopharma Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $3.65638. Pessimistic: $3.39. Optimistic: $3.80
Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 3.66 | 3.43 | 3.91 | 12.22 |
Feb | 3.56 | 3.34 | 3.73 | 10.40 |
Mar | 3.48 | 3.29 | 3.66 | 10.20 |
Apr | 3.34 | 3.21 | 3.56 | 9.64 |
May | 3.31 | 3.23 | 3.50 | 7.67 |
Jun | 3.26 | 3.04 | 3.32 | 8.39 |
Jul | 3.26 | 3.04 | 3.42 | 11.24 |
Aug | 3.34 | 3.28 | 3.55 | 7.63 |
Sep | 3.20 | 2.99 | 3.42 | 12.48 |
Oct | 3.18 | 3.07 | 3.29 | 6.96 |
Nov | 3.17 | 2.99 | 3.23 | 7.41 |
Dec | 3.37 | 3.21 | 3.50 | 8.33 |
Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 3.56 | 3.46 | 3.63 | 4.85 |
Feb | 3.54 | 3.36 | 3.65 | 7.85 |
Mar | 3.84 | 3.76 | 3.94 | 4.47 |
Apr | 3.69 | 3.58 | 3.95 | 9.34 |
May | 3.96 | 3.77 | 4.07 | 7.28 |
Jun | 3.98 | 3.81 | 4.20 | 9.22 |
Jul | 3.95 | 3.87 | 4.06 | 4.64 |
Aug | 3.97 | 3.85 | 4.10 | 6.18 |
Sep | 3.88 | 3.69 | 4.09 | 9.73 |
Oct | 4.02 | 3.75 | 4.21 | 10.93 |
Nov | 4.11 | 3.99 | 4.28 | 6.66 |
Dec | 4.33 | 4.11 | 4.62 | 11.05 |
Arbutus Biopharma information and performance
100-8900 GLENLYON PARKWAY, BURNABY, BC, CA
Market capitalization of the Arbutus Biopharma Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABUS shares in the company outstanding by the market price of one share.
EBITDA of Arbutus Biopharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.